To help investigate the effect of CCL17/TARC on MEK1/2-ERK1/2 activation in MCPyV-associated MCC, we stimulated MCC13 cells with recombinant human CCL17/TARC. This evidence concerns the gene MAP2K1 and Merkel cell skin cancer.